Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/GENKYOTEX-SA-56536861/news/Genkyotex-receives-approval-from-the-ANSM-to-initiate-a-Phase-1-clinical-study-with-high-dose-seta-30596812/?utm_source=whatsapp&utm_medium=social&utm_campaign=share